Slides
Page 1
XENON Topline Results from XEN1101 " X - TOLE " Phase 2b Clinical Trial OCTOBER 4 , 2021 NASDAQ : XENE www.xenon-pharma.com
Loading workspace
XENON Topline Results from XEN1101 " X - TOLE " Phase 2b Clinical Trial OCTOBER 4 , 2021 NASDAQ : XENE www.xenon-pharma.com
Your watchlist and earnings event details are available after you sign in.